Robust anti-tumor activity of the novel KIF18A inhibitor, ATX-295, in preclinical models of chromosomally instable tumors

ATX-295 - Accent Therap

https://www.abstractsonline.com/pp8/#!/21436/presentation/8758

Laura Ghisolfi1; Maureen M. Lynes1; April Greene-Colozzi1; David Sutton1; Jie Wu1; Livia Shehaj1; Brian A. Sparling1; Inbal Gazy2; Stuart J. Ince1; Jason A. Sager1; Serena J. Silver1

Mar 18, 2026